The effects of V2 antagonist (OPC-31260) on endolymphatic hydrops

Characterization of a novel aquaretic agent, OPC‐31260, as an orally effective, nonpeptide vasopressin V₂ receptor antagonist

Yoshitaka Yamamura, Hidenori Ogawa, Hiroshi Yamashita et al. · British Journal of Pharmacology · 1992 · 347 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Localization and regulation of PKA-phosphorylated AQP2 in response to V₂-receptor agonist/antagonist treatment

Birgitte Mønster Christensen, Marina Zelenina, Anita Aperia et al. · American Journal of Physiology-Renal Physiology · 2000 · 198 citations

Life Sciences, Pharmacology, Physiology +17

Endolymphatic hydrops induced by chronic administration of vasopressin

Taizo Takeda, Setsuko Takeda, Hiroya Kitano et al. · Hearing Research · 2000 · 147 citations

Life Sciences, Pharmacology, Physiology +10

Antidiuretic Hormone (ADH) and Endolymphatic Hydrops

Taizo Takeda, Akinobu Kakigi, Haruo Saito · Acta Oto-Laryngologica · 1995 · 129 citations

Medicine, Endocrinology, Otolaryngology +15

The effect of anti-diuretic hormone on the endolymphatic sac of the inner ear

Hidetaka Kumagami, Hubert Loewenheim, Eric Beitz et al. · Pflügers Archiv - European Journal of Physiology · 1998 · 125 citations

Medicine, Endocrinology, Physiology +13